Class A CpG oligodeoxynucleotide inhibits IFN‐γ‐induced signaling and apoptosis in lung cancer-Reference-Cited by-同舟云学术

Class A CpG oligodeoxynucleotide inhibits IFN‐γ‐induced signaling and apoptosis in lung cancer

Published:2020-04 Issue:4 Volume:11 Page:983-992
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Teranishi Shuhei¹,Kobayashi Nobuaki¹^ORCID,Katakura Seigo¹,Kamimaki Chisato²,Kubo Sousuke²,Shibata Yuji¹,Yamamoto Masaki²,Kudo Makoto²,Piao Hongmei³,Kaneko Takeshi¹

Affiliation:

1. Department of PulmonologyYokohama City University Graduate School of Medicine Yokohama Japan

2. Respiratory Disease CenterYokohama City University Medical Center Yokohama Japan

3. Department of Respiratory MedicineAffiliated Hospital of Yanbian University Yanji China

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13351

Reference35 articles.

1. SnapShot: Immune Checkpoint Inhibitors

2. The Evolving Role of Nivolumab in Non–Small-Cell Lung Cancer for Second-Line Treatment: A New Cornerstone for Our Treatment Algorithms. Results From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology

3. Targeting PD1–PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells

4. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

5. Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of the tumor microenvironment in the resistance to programmed cell death protein 1 inhibitors in patients with gastric cancer;World Journal of Gastrointestinal Oncology;2024-09-15

2. Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer;Cytokine;2023-11

3. Role of interferon-gamma (IFN-γ) and IFN-γ receptor 1/2 (IFNγR1/2) in regulation of immunity, infection, and cancer development: IFN-γ-dependent or independent pathway;Biomedicine & Pharmacotherapy;2022-11

4. Immunohistochemical Detection of TNF-α and IFN-γ Expressions in the Lungs of Sheep with Pulmonary Adenocarcinomas;Acta Veterinaria Eurasia;2022-09-19

5. T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer;Thoracic Cancer;2021-05-04